71 related articles for article (PubMed ID: 38572921)
1. Spatial proximity of tumor-immune interactions predicts patient outcome in hepatocellular carcinoma.
Maestri E; Kedei N; Khatib S; Forgues M; Ylaya K; Hewitt SM; Wang L; Chaisaingmongkol J; Ruchirawat M; Ma L; Wang XW
Hepatology; 2024 Apr; 79(4):768-779. PubMed ID: 37725716
[TBL] [Abstract][Full Text] [Related]
2. Wide surgical margins improve prognosis for HCC with microvascular invasion.
Lin WD; Ye LN; Song ZS; Wang KP; Feng YF; Pan CY
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2052-2059. PubMed ID: 36930503
[TBL] [Abstract][Full Text] [Related]
3. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.
Zhang X; Li J; Shen F; Lau WY
J Gastroenterol Hepatol; 2018 Feb; 33(2):347-354. PubMed ID: 28589639
[TBL] [Abstract][Full Text] [Related]
4. Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing.
Zheng L; Wang Y; Liu Z; Wang Z; Tao C; Wu A; Li H; Xiao T; Li Z; Rong W
Cancer Med; 2024 Apr; 13(7):e7043. PubMed ID: 38572921
[TBL] [Abstract][Full Text] [Related]
5. CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence.
Ambrozkiewicz F; Trailin A; Červenková L; Vaclavikova R; Hanicinec V; Allah MAO; Palek R; Třeška V; Daum O; Tonar Z; Liška V; Hemminki K
BMC Cancer; 2022 Aug; 22(1):884. PubMed ID: 35962322
[TBL] [Abstract][Full Text] [Related]
6. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA.
Zhou C; Weng J; Liu S; Zhou Q; Hu Z; Yin Y; Lv P; Sun J; Li H; Yi Y; Shen Y; Ye Q; Shi Y; Dong Q; Liu C; Zhu X; Ren N
Hepatol Int; 2023 Dec; 17(6):1461-1476. PubMed ID: 37217808
[TBL] [Abstract][Full Text] [Related]
9. Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
Cha DI; Kang TW; Jeong WK; Kim JM; Choi GS; Joh JW; Yi NJ; Ahn SH
Eur Radiol; 2024 Jan; 34(1):498-508. PubMed ID: 37505248
[TBL] [Abstract][Full Text] [Related]
10. Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial.
Rong W; Xia H; Zhang K; Zhang Y; Tao C; Wu F; Wang L; Zhang H; Sun G; Wu J
Hepatobiliary Surg Nutr; 2022 Dec; 11(6):834-847. PubMed ID: 36523946
[TBL] [Abstract][Full Text] [Related]
11. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
12. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.
Llovet JM; De Baere T; Kulik L; Haber PK; Greten TF; Meyer T; Lencioni R
Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):293-313. PubMed ID: 33510460
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma.
Llovet JM; Kelley RK; Villanueva A; Singal AG; Pikarsky E; Roayaie S; Lencioni R; Koike K; Zucman-Rossi J; Finn RS
Nat Rev Dis Primers; 2021 Jan; 7(1):6. PubMed ID: 33479224
[TBL] [Abstract][Full Text] [Related]
14. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
Ningarhari M; Caruso S; Hirsch TZ; Bayard Q; Franconi A; Védie AL; Noblet B; Blanc JF; Amaddeo G; Ganne N; Ziol M; Paradis V; Guettier C; Calderaro J; Morcrette G; Kim Y; MacLeod AR; Nault JC; Rebouissou S; Zucman-Rossi J
J Hepatol; 2021 May; 74(5):1155-1166. PubMed ID: 33338512
[TBL] [Abstract][Full Text] [Related]
15. The landscape of gene mutations in cirrhosis and hepatocellular carcinoma.
Müller M; Bird TG; Nault JC
J Hepatol; 2020 May; 72(5):990-1002. PubMed ID: 32044402
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
